{"title":"中枢神经系统细菌性感染的治疗——药物经济学分析。","authors":"D Dimitrov","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The meningitis and the meningoencefalitis is 29% from all of the organic diseases of the Central Nerve System. The actuality of this problem is determined by the following factors: 1. Social-only the childish group and the active group of workers among the adults are concerned; 2. The diseases are taking their course seriously with a high percentage of lethality-30%; 3. When there is untimely and inadequate therapy, there occurred additional manifestations of the disease.</p>","PeriodicalId":9085,"journal":{"name":"Bollettino chimico farmaceutico","volume":"142 10","pages":"447-9"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of patients with bacterial infections of the central nervous system--a pharmaco-economical analysis.\",\"authors\":\"D Dimitrov\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The meningitis and the meningoencefalitis is 29% from all of the organic diseases of the Central Nerve System. The actuality of this problem is determined by the following factors: 1. Social-only the childish group and the active group of workers among the adults are concerned; 2. The diseases are taking their course seriously with a high percentage of lethality-30%; 3. When there is untimely and inadequate therapy, there occurred additional manifestations of the disease.</p>\",\"PeriodicalId\":9085,\"journal\":{\"name\":\"Bollettino chimico farmaceutico\",\"volume\":\"142 10\",\"pages\":\"447-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bollettino chimico farmaceutico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bollettino chimico farmaceutico","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment of patients with bacterial infections of the central nervous system--a pharmaco-economical analysis.
The meningitis and the meningoencefalitis is 29% from all of the organic diseases of the Central Nerve System. The actuality of this problem is determined by the following factors: 1. Social-only the childish group and the active group of workers among the adults are concerned; 2. The diseases are taking their course seriously with a high percentage of lethality-30%; 3. When there is untimely and inadequate therapy, there occurred additional manifestations of the disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
